DRTS
Alpha Tau Medical Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$15.03
+2.80%0
Insider buys (3m)
10
Insider sells (3m)
-$1.2M
Net value (3m)
+61.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Levy Raphi · officer: Chief Financial Officer | M-Exempt | 2,871 | $2.98 |
| Aug 25, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 2,871 | $15 |
| Aug 12, 2026 | Levy Raphi · officer: Chief Financial Officer | M-Exempt | 17,730 | $2.98 |
| Aug 12, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 17,730 | $14 |
| Jul 7, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 2,270 | $14 |
| Jul 7, 2026 | Levy Raphi · officer: Chief Financial Officer | M-Exempt | 2,270 | $2.98 |
| Jul 6, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 17,873 | $13 |
| Jul 6, 2026 | Levy Raphi · officer: Chief Financial Officer | M-Exempt | 17,873 | $2.98 |
| Jul 2, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 2,127 | $13 |
| Jul 2, 2026 | Levy Raphi · officer: Chief Financial Officer | M-Exempt | 2,127 | $2.98 |
| Jul 1, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 20,000 | $12 |
| Jun 26, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 15,778 | $11 |
| Jun 26, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 4,222 | $11 |
| Jun 25, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 2,500 | $10 |
| Jun 25, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 15,000 | $9.47 |
| Jun 4, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 17,500 | $11 |
| Jun 4, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 15,000 | $11 |
Institutional positioning
13F filings over the trailing two quarters
New 19Increased 9Reduced 15Sold out 53
| Filer | Action | Shares | Filed |
|---|---|---|---|
| HIGHTOWER ADVISORS, LLC | Increased | 874,994 | May 5, 2026 |
| Aquamarine Financial (Cayman) Ltd | New Position | 721,501 | May 15, 2026 |
| APELLA CAPITAL, LLC | Unchanged | 382,284 | Apr 20, 2026 |
| CITADEL ADVISORS LLC | Increased | 375,459 | Sep 2, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | New Position | 292,134 | May 12, 2026 |
| UBS GROUP AG | Increased | 286,688 | May 5, 2026 |
| KOVITZ INVESTMENT GROUP PARTNERS, LLC | Reduced | 147,138 | May 13, 2026 |
| MARINER, LLC | Increased | 146,396 | May 13, 2026 |
| Daytona Street Capital LLC | Reduced | 146,106 | Apr 10, 2026 |
| CITADEL ADVISORS LLC | Increased | 140,395 | May 15, 2026 |
| GEM INVESTMENT ADVISORS, LLC | Reduced | 113,736 | May 15, 2026 |
| LEVIN CAPITAL STRATEGIES, L.P. | Reduced | 106,423 | May 13, 2026 |
| JANE STREET GROUP, LLC | New Position | 102,839 | May 12, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New Position | 83,438 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 53,399 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 25, 2026